Table 1.
ATZ | LPRT | REM | FAV | CHL | NIT | RIB | TOC | |
---|---|---|---|---|---|---|---|---|
Haloperidol | ↑♥ | ↑♥ | ↔ | ↔ | ↔♥ | ↔ | ↔ | ↔ |
Olanzapine | ↔ | ↓ | ↔ | ↔ | ↔ | ↔ | ↔ | ↔ |
Risperidone | ↑♥ | ↑♥ | ↔ | ↔ | ↑♥ | ↔ | ↔ | ↔ |
Quetiapine | ↑♥ | ↑♥ | ↔ | ↔ | ↔♥ | ↔ | ↔ | ↔ |
Diazepam | ↑ | ↑ | ↔ | ↔ | ↔ | ↔ | ↔ | ↔ |
Lorazepam | ↔ | ↔ | ↔ | ↔ | ↔ | ↔ | ↔ | ↔ |
Midazolam | ↑ | ↑ | ↔ | ↔ | ↔ | ↔ | ↔ | ↔ |
ATZ, atazanavir; LPRT, lopinavir/ritonavir; REM, remdesivir; FAV, favipiravir; CHL, chloroquine/hydroxychloroquine; NIT, nitazonide; RIB, ribavirin; TOC, tocilizumab.
↑ indicates potential for increased medication effects and ↓ indicates potential for decreased medication effects. ♥ indicates potential cardiac toxicity that may cause QT and/or PR prolongation.